Virion Biotherapeutics is Biotechnology in United Kingdom that focus on respiratory syncytial virus business. Founded in 2015. They cover business area such as developer, biological antiviral, improved therapeutic, respiratory viral infection, prevention, treatment, influenza, respiratory syncytial virus, RSV, doctor, differential diagnosis.
2015
( 9 years old in 2024 )
Respiratory Syncytial Virus
-
38 Jermyn Street
London SW1 6DN
England, United Kingdom
Private
developerbiological antiviralimproved therapeuticrespiratory viral infectionpreventiontreatmentinfluenzarespiratory syncytial virusRSVdoctordifferential diagnosis
* We use standard office opening hours in near Virion Biotherapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Virion Biotherapeutics is Biotechnology business from United Kingdom that founded in 2015 (9 years old in 2024), Virion Biotherapeutics business is focusing on Respiratory Syncytial Virus.
Virion Biotherapeutics headquarter office and corporate office address is located in 38 Jermyn Street London SW1 6DN England, United Kingdom.
Virion Biotherapeutics was founded in United Kingdom.
In 2024, Virion Biotherapeutics is currently focus on respiratory syncytial virus sector.
Above is snippet of Google Trends for "respiratory syncytial virus" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Virion Biotherapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
